IP Library Granted Patent US 7,643,858
Granted Patent B2
US 7,643,858 · App. 11/529,024 · Granted Jan 5, 2010

System and method for detection of brain edema using spectrophotometry

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,643,858
App. No.
11/529,024
Granted
Jan 5, 2010
Kind
B2
Abstract

Embodiments of the present invention relate to a system and method of detecting or monitoring brain edema in a patient. One embodiment of the present invention includes emitting a first light into the patient's brain tissue at a first wavelength, emitting a second light into the patient's brain tissue at a second wavelength, detecting the first and second lights after dispersion by the brain tissue at a detector, and determining an amount of water proximate the brain tissue based on the detected first and second lights.

Claims (28)

1. A method of detecting or monitoring brain edema in a patient, comprising:

emitting a first light into the patient's brain tissue at a first wavelength through a partial bone region of the patient's skull, wherein the partial bone region of the patient's skull is approximately 3 cm behind a coronal suture of the patient's skull, wherein the coronal suture includes a suture between parietal and frontal bones of the patient's skull;

emitting a second light into the patient's brain tissue at a second wavelength through said partial bone region;

detecting the first and second lights after dispersion by the brain tissue at a detector; and

determining an amount of water proximate the brain tissue based on the detected first and second lights.

2. The method of claim 1 , comprising emitting a third light into the patient's brain tissue at a third wavelength.

3. The method of claim 2 , comprising detecting the third light after reflection or dispersion by the brain tissue.

4. The method of claim 3 , comprising determining the amount of water proximate the brain tissue based on the detected third light in combination with the detected first and second lights.

5. The method of claim 1 , comprising emitting the first and second lights from at least approximately 5 mm away from the detector.

6. The method of claim 1 , comprising emitting the first and second lights from approximately 10-30 mm away from the detector.

7. The method of claim 1 , comprising emitting the first and second lights from approximately 1-5 mm away from the detector.

8. The method of claim 1 , comprising penetrating approximately 16 mm into the patient with the first and second lights.

9. The method of claim 1 , wherein the first and second wavelengths are within a 1050-1350 nm spectral region.

10. The method of claim 1 , wherein the first and second wavelengths are within a 1500-1800 nm spectral region.

11. The method of claim 1 , wherein the first and second wavelengths are within a 2100-2300 nm spectral region.

12. The method of claim 2 , comprising emitting the third light into the brain tissue via the partial bone region.

13. A method of detecting or monitoring brain edema in a patient, comprising:

emitting a first light into the patient's brain tissue at a first wavelength approximately 1-5 mm away from a detector, wherein the first wavelength is within a 2100-2300 nm spectral region and wherein the first light is emitted through a partial bone region of the patient's skull approximately 3 cm behind a coronal suture of the patient's skull, wherein the coronal suture includes a suture between parietal and frontal bones of the patient's skull;

emitting a second light into the patient's brain tissue at a second wavelength approximately 1-5 mm away from the detector, wherein the second wavelength is within the 1500-2300 nm spectral region and wherein the second light is emitted through said partial bone region;

detecting the first and second lights after dispersion by the brain tissue at the detector; and

determining an amount of water proximate the brain tissue based on the detected first and second lights.

14. The method of claim 13 , comprising detecting a pressure within the patient's skull.

15. The method of claim 14 , comprising determining a perfusion status and a tissular hydration value based on the pressure and the detection of the first and second lights.

16. A method of detecting or monitoring brain edema in a patient, comprising:

emitting a first light into the patient's brain tissue at a first wavelength approximately 10-30 mm away from a detector through a partial bone region of the patient's skull approximately 3 cm behind a coronal suture of the patient's skull, wherein the coronal suture includes a suture between parietal and frontal bones of the patient's skull, and wherein the first wavelength is within a 1050-1350 nm spectral region;

emitting a second light into the patient's brain tissue at a second wavelength approximately 10-30 mm away from the detector through said partial bone region, wherein the second wavelength is within the 1050-1350 nm spectral region;

detecting the first and second lights after dispersion by the brain tissue at the detector; and

determining an amount of water proximate the brain tissue based on the detected first and second lights.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029346/0724 →
CHANGE OF NAME Recorded Aug 6, 2009
From: AGASHE, GEETA; DEBRECZENY, MARTIN
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 023061/0424 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2006
From: AGASHE, GEETA; DEBRECZENY, MARTIN
To: NELLCOR PURITAN BENNETT INCORPORATED
Reel/Frame 018730/0640 →